triflusal has been researched along with 6-ketoprostaglandin f1 alpha in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de la Cruz, JP; Mata, JM; Sanchez de la Cuesta, F | 1 |
| Conget, JI; Esmatjes, E; Fernandez, MR; Ferrer, JP; Gaya, J; Rivera, F; Vilardell, E | 1 |
| Dominguez, MJ; Forn, J; Iriarte, JA; Olabarría, I; Sáez, Y; Vacas, M; Velasco, A | 1 |
| Auteri, A; Di Perri, T; Franchi, M; Messa, GL | 1 |
1 trial(s) available for triflusal and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Action of 2-acetoxy-trifluoromethylbenzoic acid (Triflusal) on platelet function after repeated oral administration in man: a pharmacological clinical study.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Aged; beta-Thromboglobulin; Blood Platelet Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 3; Platelet Factor 4; Salicylates; Thromboxane B2 | 1993 |
3 other study(ies) available for triflusal and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Mesenteric Arteries; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Salicylates; Thromboxane B2 | 1992 |
Effects of thromboxane synthesis inhibitor triflusal on renal hemodynamics in microalbuminuric diabetic patients.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 1; Dinoprostone; Female; Glomerular Filtration Rate; Humans; Male; Platelet Aggregation Inhibitors; Renal Circulation; Renin; Salicylates; Thromboxane B2 | 1990 |
Effects of triflusal in patients with prosthetic heart valves.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Count; Salicylates | 1985 |